ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Maravai LifeSciences Holdings Inc

Maravai LifeSciences Holdings Inc (MRVI)

7.55
-0.18
( -2.33% )
Updated: 14:05:58

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
7.55
Bid
7.55
Ask
7.56
Volume
501,687
7.52 Day's Range 7.76
4.52 52 Week Range 16.62
Market Cap
Previous Close
7.73
Open
7.71
Last Trade Time
14:06:05
Financial Volume
$ 3,820,287
VWAP
7.6149
Average Volume (3m)
2,879,878
Shares Outstanding
251,399,871
Dividend Yield
-
PE Ratio
-16.09
Earnings Per Share (EPS)
-0.47
Revenue
292.23M
Net Profit
-119.03M

About Maravai LifeSciences Holdings Inc

Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, novel vaccines and support research on human diseases. The company's segments are Nucleic acid production, Biologics safety testing, and Protein detection. It ... Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, novel vaccines and support research on human diseases. The company's segments are Nucleic acid production, Biologics safety testing, and Protein detection. It generates a majority of its revenue from the Nucleic Acid Production that focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
1970
Maravai LifeSciences Holdings Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker MRVI. The last closing price for Maravai LifeSciences was $7.73. Over the last year, Maravai LifeSciences shares have traded in a share price range of $ 4.52 to $ 16.62.

Maravai LifeSciences currently has 251,399,871 shares outstanding. The market capitalization of Maravai LifeSciences is $1.92 billion. Maravai LifeSciences has a price to earnings ratio (PE ratio) of -16.09.

MRVI Latest News

TriLink BioTechnologies® Announces New San Diego Facility for Late Phase mRNA Drug Substance Production

cGMP Facility Streamlines Clinical & Commercial mRNA Drug Substance Development; Built by mRNA & Industry Experts to Meet Demand for mRNA-based Medicine TriLink BioTechnologies...

Maravai LifeSciences To Host Earnings Conference Call on Wednesday, May 8, 2024

SAN DIEGO, April 10, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators...

Maravai LifeSciences Announces March 2024 Investor Conference Schedule

SAN DIEGO, March 12, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is...

Maravai LifeSciences Reports Fourth Quarter and Full Year 2023 Financial Results

SAN DIEGO, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech...

TriLink BioTechnologies® Solidifies IP Position with Awarded Patents for CleanCap® Capping Technology in China and Canada

TriLink’s CleanCap® Capping Technology is Patented Globally & TriLink is the Sole Authorized Manufacturer of CleanCap® Capping Analogs TriLink BioTechnologies (TriLink®), a Maravai...

Dyadic and Cygnus Technologies Announce Partnership To Provide C1 HCP ELISA Assay to Enhance Quality Assurance in Biomanufacturing

JUPITER, Fla. and LELAND, N.C., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Dyadic International Inc. (“Dyadic”, or the “Company”) (Nasdaq: DYAI) and Cygnus Technologies®, part of Maravai LifeSciences®...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-1.14-13.11852704268.698.737.48515652418.17037761CS
4-0.65-7.926829268298.28.927.48524671158.39898228CS
121.3421.5780998396.218.925.04528798787.40792221CS
260.010.1326259946957.548.924.5226336826.65256594CS
52-6.72-47.091800981114.2716.624.5226423809.24553052CS
156-29.11-79.405346426636.6663.554.52195933920.88344826CS
260-23.56-75.73127611731.1163.554.52190173421.89414483CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AGBAAGBA Group Holding Ltd
$ 1.03
(157.50%)
106.06M
TIRXTian Ruixiang Holdings Ltd
$ 0.8511
(75.58%)
55.84M
ISPCiSpecimen Inc
$ 0.373548
(75.37%)
9.41M
BPTHBio Path Holdings Inc
$ 4.95
(52.78%)
75.49M
XPONExpion360 Inc
$ 2.8496
(47.65%)
9.85M
INVZWInnoviz Technologies Ltd
$ 0.1675
(-35.58%)
501
WISAWiSA Technologies Inc
$ 6.31
(-31.78%)
14.22M
RCATRed Cat Holdings Inc
$ 0.9823
(-30.82%)
3.33M
STISolidion Technology Inc
$ 1.40
(-29.29%)
420.88k
SPCBSuperCom Ltd
$ 0.259
(-28.04%)
6.71M
SINTSiNtx Technologies Inc
$ 0.0514
(37.80%)
372.96M
SQQQProShares UltraPro Short QQQ
$ 12.10
(2.02%)
131.67M
AGBAAGBA Group Holding Ltd
$ 1.03
(157.50%)
106.07M
BPTHBio Path Holdings Inc
$ 4.95
(52.78%)
75.49M
TSLATesla Inc
$ 149.555
(-3.79%)
72.93M

MRVI Discussion

View Posts
Monksdream Monksdream 2 months ago
MRVI No 2 on the Barchart 100
https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc
👍️0
Monksdream Monksdream 2 months ago
Early Barchart 100
https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc
👍️0
crudeoil24 crudeoil24 3 years ago
Maravai LifeSciences stock price target raised to $50 from $31 at Stifel Nicolaus
7:24 am ET March 3, 2021 (MarketWatch)
👍️0
crudeoil24 crudeoil24 3 years ago
Maravai LifeSciences shares are trading higher after the company reported better-than-expected Q4 EPS and sales results and issued FY21 EPS and sales guidance above estimates.

Mar 3, 2021 7:35a ETBenzinga Stock Analysis
👍️0
crudeoil24 crudeoil24 3 years ago
Maravai LifeSciences Holdings, Inc. is a life sciences company. The Company provides products that enables the development of drug therapies, diagnostics, vaccines and support research on human diseases. The Company's segments include Nucleic Acid Production, Biologics Safety Testing, and Protein Detection. The Nucleic Acid Production segment manufactures and sells products used in the fields of gene therapy, nucleoside chemistry, oligonucleotide therapy and molecular diagnostics, including reagents used in the chemical synthesis, modification, labelling and purification of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). Its Biologics Safety Testing segment sells specialized analytical products for use in biologic manufacturing process development, including custom product-specific development antibody and assay development services. The Company's Protein Detection segment sells labeling and detection reagents for researchers in immunohistochemistry.
👍️0

Your Recent History

Delayed Upgrade Clock